FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, in particular to pharmacology, namely to the agent 3-(N-pyrrolyl)propanoyl-L-histidine of the general structural formula (1). The proposed remedy has antioxidant and neuroprotective activity.
EFFECT: expanding the arsenal of drugs with high antioxidant and neuroprotective activity.
1 cl, 12 dwg, 3 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT WITH NEUROPROTECTIVE ANTI-ISCHEMIC ACTIVITY | 2022 |
|
RU2780112C1 |
LIPOIC ACID MYCELIAL COMPLEX WITH CARNOSINE FOR MAMMALS PROTECTION AGAINST OXIDATIVE STRESS | 2016 |
|
RU2647435C2 |
NEUROPROTECTIVE AGENT | 2016 |
|
RU2614697C1 |
AGENT POSSESSING ANTIAGGREGANT, CYTOPROTECTIVE AND ANTIOXIDANT ACTIVITY | 2018 |
|
RU2694061C1 |
PHARMACEUTICAL COMPOSITIONS FOR TREATING PARKINSON'S DISEASE | 2009 |
|
RU2540470C9 |
METHOD FOR ASSESSING COMPLEX PROTECTION OF CELLS UNDER NEURO-INFLAMMATORY ON IN VITRO MODELS UNDER EXPOSURE TO PAR1 AGONIST | 2022 |
|
RU2796524C1 |
AGENT FOR TREATMENT OF BRAIN ISCHEMIC INJURY | 2004 |
|
RU2288714C2 |
USE OF L-CARNOSINE FOR PRODUCING NANOPREPARATION POSSESSING ANTIHYPOXIC AND ANTIOXIDANT ACTIVITY | 2012 |
|
RU2482867C1 |
METHOD FOR PREVENTING AND CORRECTING METABOLIC AND FUNCTIONAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM UNDER STRESS CONDITIONS | 2019 |
|
RU2717107C1 |
DONECOPRID AS A NEUROPROTECTIVE AGENT IN THE TREATMENT OF NEURODEGERATIVE DISEASES | 2019 |
|
RU2800802C2 |
Authors
Dates
2022-08-03—Published
2021-11-17—Filed